1.
J Clin Endocrinol Metab
; 92(5): 1616, 2007 May.
Article
in English
| MEDLINE
| ID: mdl-17483375
Subject(s)
Carcinoma, Large Cell/complications , Carcinoma, Large Cell/metabolism , Hypoglycemia/etiology , Insulin-Like Growth Factor I/metabolism , Lung Neoplasms/complications , Lung Neoplasms/metabolism , Paraneoplastic Endocrine Syndromes/complications , Paraneoplastic Endocrine Syndromes/metabolism , Female , Humans , Insulin-Like Growth Factor I/chemistry , Insulin-Like Growth Factor II/chemistry , Insulin-Like Growth Factor II/metabolism , Molecular Weight
2.
Growth Horm IGF Res
; 16 Suppl A: S3-5, 2006 Jul.
Article
in English
| MEDLINE
| ID: mdl-16690339
ABSTRACT
Fifty years ago there was no practical method for measuring growth hormone (GH) activity in human plasma. In an attempt to develop such an assay, it was determined that much of the action of GH in vivo on rat cartilage was mediated by a serum factor that was first known as sulfation factor, and later as somatomedin and insulin-like growth factor. This narrative describes my experience and that of others in this important area of endocrine research.
Subject(s)
Endocrinology/history , Somatomedins/history , Animals , Cattle , Child , History, 20th Century , History, 21st Century , Humans , Rats
3.
N Engl J Med
; 350(18): 1906; author reply 1906, 2004 Apr 29.
Article
in English
| MEDLINE
| ID: mdl-15115839
4.
J Clin Endocrinol Metab
; 89(1): 3-5, 2004 Jan.
Article
in English
| MEDLINE
| ID: mdl-14715816
